Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Epilepsy Curr ; 21(1): 33-35, 2021.
Article in English | MEDLINE | ID: mdl-34025271
2.
J Investig Med ; 64(6): 1087-101, 2016 08.
Article in English | MEDLINE | ID: mdl-27252470

ABSTRACT

Ezogabine, clobazam, and perampanel are among the newest antiseizure drugs approved by the Food and Drug Administration between 2011 and 2012. Ezogabine and perampanel are approved for adjunctive treatment of partial epilepsy. Perampanel is also approved for adjunctive treatment of primary generalized tonic-clonic seizures. Ezogabine and perampanel have novel mechanisms of action. Ezogabine binds to voltage-gated potassium channels and increases the M-current thereby causing membrane hyperpolarization. Perampanel is a selective, non-competitive 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid receptor antagonist, which reduces neuronal excitation. Clobazam has been used worldwide since the 1970s and is approved for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome. Clobazam is the only 1,5-benzodiazepine currently in clinical use, which is less sedating than the commonly used 1,4-benzodiazepines. Phase III multicenter, randomized, double-blind, placebo-controlled trials demonstrated efficacy and good tolerability of these 3 new antiepileptic drugs. These drugs represent a welcome addition to the armamentarium of practitioners, but it remains to be seen how they will affect the landscape of pharmacoresistant epilepsy.


Subject(s)
Anticonvulsants/therapeutic use , Benzodiazepines/therapeutic use , Carbamates/therapeutic use , Phenylenediamines/therapeutic use , Pyridones/therapeutic use , Anticonvulsants/adverse effects , Anticonvulsants/pharmacokinetics , Anticonvulsants/pharmacology , Benzodiazepines/adverse effects , Benzodiazepines/pharmacokinetics , Benzodiazepines/pharmacology , Carbamates/adverse effects , Carbamates/pharmacokinetics , Carbamates/pharmacology , Clobazam , Humans , Nitriles , Phenylenediamines/adverse effects , Phenylenediamines/pharmacokinetics , Phenylenediamines/pharmacology , Pyridones/adverse effects , Pyridones/pharmacokinetics , Pyridones/pharmacology , Treatment Outcome
3.
Neurol Clin ; 34(2): 411-25, ix, 2016 May.
Article in English | MEDLINE | ID: mdl-27086987

ABSTRACT

Epilepsy and antiepileptic drugs affect the menstrual cycle, aspects of contraception, reproductive health, pregnancy, and menopause through alteration of sex steroid hormone pathways. Sex steroid hormones often have an effect on seizure frequency and may alter the level of some antiepileptic drugs. Approximately one-third of women experience an increase in perimenstrual and/or periovulatory seizure frequency. Some women experience an increase in seizure frequency during pregnancy. Balancing maternal seizure control and the risk of congenital malformations associated with fetal antiepileptic drug exposure may be challenging. Some antiepileptic drugs are associated with cognitive and behavioral teratogenesis and should be avoided if possible during pregnancy.


Subject(s)
Anticonvulsants/therapeutic use , Epilepsy/drug therapy , Menopause/drug effects , Menstrual Cycle/drug effects , Pregnancy Complications/chemically induced , Epilepsy/physiopathology , Female , Humans , Pregnancy
4.
Drug Saf ; 38(3): 271-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25693658

ABSTRACT

Many studies investigating cognitive outcomes in children of women with epilepsy report an increased risk of mental impairment. Verbal scores on neuropsychometric measures may be selectively more involved. While a variety of factors contribute to the cognitive problems of children of women with epilepsy, antiepileptic drugs (AEDs) appear to play a major role. The mechanisms by which AEDs affect neurodevelopmental outcomes remain poorly defined. Animal models suggest that AED-induced apoptosis, altered neurotransmitter environment, and impaired synaptogenesis are some of the mechanisms responsible for cognitive and behavioral teratogenesis. AEDs that are known to induce apoptosis, such as valproate, appear to affect children's neurodevelopment in a more severe fashion. Fetal valproate exposure has dose-dependent associations with reduced cognitive abilities across a range of domains, and these appear to persist at least until the age of 6. Some studies have shown neurodevelopmental deficiencies associated with the use of phenobarbital and possibly phenytoin. So far, most of the investigations available suggest that fetal exposures to lamotrigine or levetiracetam are safer with regard to cognition when compared with other AEDs. Studies on carbamazepine show contradictory results, but most information available suggests that major poor cognitive outcomes should not be attributed to this medication. Overall, children exposed to polytherapy prenatally appear to have worse cognitive and behavioral outcomes compared with children exposed to monotherapy, and with the unexposed. There is an increase risk of neurodevelopmental deficits when polytherapy involves the use of valproate versus other agents.


Subject(s)
Anticonvulsants/pharmacology , Epilepsy/drug therapy , Fetal Development/drug effects , Neurodevelopmental Disorders , Pregnancy Complications/drug therapy , Prenatal Exposure Delayed Effects/chemically induced , Female , Humans , Neurodevelopmental Disorders/etiology , Neurodevelopmental Disorders/prevention & control , Pregnancy
5.
Semin Neurol ; 32(4): 361-73, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23361482

ABSTRACT

Neuroimaging has provided extraordinary insight into the pathologic substrate of epilepsy. The excellent spatial resolution and soft tissue contrast of magnetic resonance imaging (MRI) allows identification of a substantial number of pathologies including hippocampal sclerosis, malformations of cortical development, low grade tumors, and vascular abnormalities, among others. Complementary imaging modalities such as positron emission tomography, single photon emission computed tomography, and magnetoencephalography can be diagnostically helpful as well. Identification of a pathologic substrate is particularly important in patients with medically refractory epilepsy who are undergoing evaluation for surgery, and essential in determining the likelihood of seizure freedom after surgical intervention. This article reviews current and emerging neuroimaging techniques in the field of epilepsy.


Subject(s)
Brain/pathology , Epilepsy/diagnosis , Neuroimaging/methods , Animals , Brain Neoplasms/diagnosis , Brain Neoplasms/epidemiology , Epilepsy/epidemiology , Hippocampus/pathology , Humans , Neuroimaging/trends , Sclerosis/diagnosis , Sclerosis/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...